About
Smarter, faster research and development with AWS and NVIDIA

Drug discovery is a complex, costly, and high-risk process. But with generative AI powered by AWS and NVIDIA, biopharma companies can accelerate research and development, reduce costs, and improve the chances of clinical success.

Join us for an engaging webinar where we explore how AI-driven tools are transforming drug discovery from target identification and protein design to virtual screening and lead optimisation.

Learn how generative AI models can help you handle massive, multi-modal datasets, predict molecular interactions, and quickly generate novel drug candidates. We’ll also discuss how AWS and NVIDIA’s purpose-built solutions—from scalable cloud infrastructure to advanced AI microservices—make it easier to deploy and scale AI models for drug discovery.

Key topics include:
  • AI-driven data integration and analysis
  • Virtual screening, protein structure prediction, and de novo drug design
  • Accelerating generative AI model deployment with AWS and NVIDIA

    Whether you're in biopharma, AI development, or data science, this webinar will provide actionable insights to accelerate your drug discovery efforts and bring innovative treatments to market faster.
    • When
    Tuesday, February 25, 2025 · 3:00 p.m. London (GMT +0:00)
    Presenters
    1733926097-1ecd7e2cc2d0e443
    Marissa E Powers, PhD
    Solutions Architect, High Performance Computing (HPC) Life Sciences at Amazon Web Services (AWS)
    Marissa E Powers, PhD is a Senior HPC Specialist Solutions Architect focused on Life Sciences. Marissa supports customers through deploying their R&D workloads on AWS, including molecular dynamics simulations, genomics pipelines, and Cryo-Electron microscopy. Marissa holds a PhD in computational neuroscience and is passionate about accelerating research and discovery.
    1733926157-75f986ea66a5e6f1
    David Ruau, PhD
    EMEA Business Development Lead, Healthcare and Life Sciences at NVIDIA
    David Ruau, PhD, is an experienced executive in the life science industry. David has a tremendous cross domain and global background previously VP, Head of Global Data Assets & Decision Science at Bayer Pharmaceuticals leading the digital transformation data science capabilities before that at Bayer and AstraZeneca leading data science teams working on clinical trial optimization, radiology/digital pathology image diagnosis, supply chain simulations and adverse event labelling using NLP. In his role at NVIDIA, David is focused on the healthcare sector across EMEA academia, startups and industry.

    David academic background is in bioinformatics analyzing -omics data and patient medical information in different therapeutic areas. David authored 30+ peer-reviewed publications and book chapters in journals like Nature, Cell, Stem Cells.
    1733926477-5687fff5a85a804c
    Neil Perry
    Group Broadcast Director at BizClik
    Neil Perry is the Group Content Director at BizClik and has two decades of multimedia experience. He has worked across regional and national brands for Global Radio, as a bulletin presenter, broadcast voice coach, mentor and news editor. Neil moved into visual broadcasting in 2014 helping to establish one of the first local television channels as an assistant news editor, and executive producer of a topical discussion programme.
    Reserve Your Spot
    Full name*
    Email Address*
    Job Title*
    Country*
    Company Name*
    We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
    Powered by BigMarker